International Iberian Nanotechnology Laboratory, Braga, 4715-330, Portugal.
ACS Nano. 2023 Sep 12;17(17):17587-17594. doi: 10.1021/acsnano.3c07204. Epub 2023 Aug 15.
Hybrid core-shell lipid-polycation-nucleic acid nanoparticles (LPNPs) provide unique delivery strategies for nonviral gene therapeutics. Since LPNPs consist of multiple components, involving different pairwise interactions between them, they are challenging to characterize and understand. Here, we propose a method based on fluorescence cross-correlation spectroscopy to elucidate the association between the three LPNP components. Through this lens, we demonstrate that cationic lipid shells (liposomes) do not displace polycations or DNA from the polycation-DNA cores (polyplexes). Hence, polyplexes and liposomes must be oppositely charged to associate into LPNPs. Furthermore, we identify the liposome:polyplex number ratio (), which was hitherto an intangible quantity, as the primary parameter predicting stable LPNPs. We establish that ≥ 1 ensures that every polyplex is enveloped by a liposome, thus avoiding coexisting oppositely charged species prone to aggregation.
杂交核壳脂质-聚阳离子-核酸纳米颗粒(LPNPs)为非病毒基因治疗提供了独特的递药策略。由于 LPNPs 由多种成分组成,涉及它们之间不同的两两相互作用,因此难以对其进行表征和理解。在这里,我们提出了一种基于荧光相关光谱的方法来阐明三种 LPNP 成分之间的关联。通过这种方法,我们证明了阳离子脂质外壳(脂质体)不会从聚阳离子-DNA 核心(聚合物)中置换聚阳离子或 DNA。因此,聚合物和脂质体必须带相反电荷才能缔合成 LPNPs。此外,我们确定了脂质体:聚合物比率(),这是一个以前无形的数量,作为预测稳定 LPNPs 的主要参数。我们确定 ≥ 1 可确保每个聚合物都被脂质体包裹,从而避免了容易聚集的共存带相反电荷的物质。